Case Studies
Trusted by over 400 researchers worldwide, Evidentic empowers scientists across academia, research labs, early drug development, biosimilar development, and cell line development.
National Institute for Bioprocessing Research and Training (NIBRT)
Quality and Service: Fast and easy ordering processes meet the needs in highly work-intense phase
ICNAS
Academia: Optimize and validate research protocols with mAb drug aliquots
ExcellGene
Biosimilars: Reference Drug Aliquots for Faster Selection and Development of CHO-based Production Processes
UGA Biopharma GmbH
Aliquots: A New Solution to the Batch Variability Problem
Deka BioSciences
Reference Drug Aliquots: The right control for Assays
Frequently asked questions
If you struggle to source clinical-grade biologics you need for your research, Evidentic bridges the gap. We offer royalty-free research consumables (RUO-only) derived from original licensed drugs, giving you access to these critical research tools without the hassle.
But that’s not all. We understand the importance of batch variety in your research. That’s why we’ve built a comprehensive stock library, offering numerous batches of the same active pharmaceutical ingredient (API). This dedication to choice means you can find the exact batch that aligns with your specific research needs.
And because we’re constantly expanding our library, you can be sure we’re actively searching for new batches to add to your research arsenal. With Evidentic, unlock the power of readily available, high-quality research tools and accelerate your scientific breakthroughs.
Evidentic’s aliquots from approved pharnaceuticals can be used for analytical, in vitro research, typically executed in early drug development stage of drug discovery programs, like:
- Use as reference molecules for your assays
- In functional in-vitro assays
- For analytical procedures
- For biosimilar and new drug early development
- To compare against your research-grade molecules
Evidentic offers access to pharmaceuticals approved by the U.S. FDA (Food and Drug Administration) and/or the EMA (European Medicines Agency). This gives you access to a wider variety of molecules for your research, potentially shortening timelines and boosting the accuracy of your results. Compare EU and US molecules head-to-head, and accelerate your early drug development projects with access to these high-quality research tools. Contact us today to explore the possibilities!